Feedback
Market Cap
UK£13.6m
Last Updated
2021/05/10 18:46 UTC
Data Sources
Company Financials
Executive Summary
Feedback plc, a medical imaging technology company, provides software and systems to those working in the field of medical imaging. More Details
Snowflake Analysis
Flawless balance sheet and overvalued.
Share Price & News
How has Feedback's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: FDBK is more volatile than 75% of UK stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: FDBK's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
Market Performance
7 Day Return
-1.9%
FDBK
-2.2%
GB Healthcare Services
2.1%
GB Market
1 Year Return
24.4%
FDBK
76.0%
GB Healthcare Services
26.3%
GB Market
Return vs Industry: FDBK underperformed the UK Healthcare Services industry which returned 76% over the past year.
Return vs Market: FDBK underperformed the UK Market which returned 26.3% over the past year.
Shareholder returns
| FDBK | Industry | Market | |
|---|---|---|---|
| 7 Day | -1.9% | -2.2% | 2.1% |
| 30 Day | 2.0% | 10.8% | 3.5% |
| 90 Day | 15.9% | 15.1% | 8.8% |
| 1 Year | 24.4%24.4% | 78.7%76.0% | 31.9%26.3% |
| 3 Year | -51.4%-51.4% | 49.6%41.8% | 12.9%-0.1% |
| 5 Year | 2.0%2.0% | 81.9%64.9% | 51.5%22.8% |
Long-Term Price Volatility Vs. Market
How volatile is Feedback's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall St
Who Has Been Buying Feedback plc (LON:FDBK) Shares?6 months ago | Simply Wall St
How Many Feedback plc (LON:FDBK) Shares Did Insiders Buy, In The Last Year?Valuation
Is Feedback undervalued compared to its fair value and its price relative to the market?
2.06x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate FDBK's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate FDBK's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: FDBK is unprofitable, so we can't compare its PE Ratio to the XE Healthcare Services industry average.
PE vs Market: FDBK is unprofitable, so we can't compare its PE Ratio to the UK market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate FDBK's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: FDBK is good value based on its PB Ratio (2.1x) compared to the GB Healthcare Services industry average (6.6x).
Future Growth
How is Feedback forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
28.9%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Feedback has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Past Performance
How has Feedback performed over the past 5 years?
-26.6%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: FDBK is currently unprofitable.
Growing Profit Margin: FDBK is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: FDBK is unprofitable, and losses have increased over the past 5 years at a rate of 26.6% per year.
Accelerating Growth: Unable to compare FDBK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: FDBK is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (8.6%).
Return on Equity
High ROE: FDBK has a negative Return on Equity (-20.12%), as it is currently unprofitable.
Financial Health
How is Feedback's financial position?
Financial Position Analysis
Short Term Liabilities: FDBK's short term assets (£4.4M) exceed its short term liabilities (£395.0K).
Long Term Liabilities: FDBK has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: FDBK is debt free.
Reducing Debt: FDBK had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: FDBK has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: FDBK has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 35.9% each year.
Dividend
What is Feedback current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate FDBK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate FDBK's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if FDBK's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if FDBK's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of FDBK's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.6yrs
Average board tenure
CEO
Tom Oakley (32 yo)
2.08yrs
Tenure
UK£170,000
Compensation
Dr. Thomas James Oakley, also known as Tom,BM(Hons) BSc (Hons), has been Chief Executive Officer of Feedback plc since April 9, 2019 and Director since October 2019. Dr Oakley has been Chief Executive Offi...
CEO Compensation Analysis
Compensation vs Market: Tom's total compensation ($USD240.35K) is about average for companies of similar size in the UK market ($USD337.80K).
Compensation vs Earnings: Tom's compensation has increased whilst the company is unprofitable.
Board Members
Experienced Board: FDBK's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 97.6%.
Top Shareholders
Company Information
Feedback plc's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Feedback plc
- Ticker: FDBK
- Exchange: AIM
- Founded: 1958
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: UK£13.603m
- Shares outstanding: 1.07b
- Website: https://fbkmed.com/feedback-plc
Number of Employees
Location
- Feedback plc
- Health Foundry
- Canterbury House
- London
- Greater London
- SE1 7LL
- United Kingdom
Listings
Biography
Feedback plc, a medical imaging technology company, provides software and systems to those working in the field of medical imaging. Its products include TexRAD, a software tool, which extracts and quantifi...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/05/10 18:46 |
| End of Day Share Price | 2021/05/10 00:00 |
| Earnings | 2020/11/30 |
| Annual Earnings | 2020/05/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.